VF
TRAW icon

Virtu Financial’s Traws Pharma TRAW Stock Holding History

Virtu Financial’s Portfolio TRAW Stock Details TRAW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-1,094
Closed -$12K – 1968
2024
Q2 		$12K Buy
+1,094
New +$17.6K ﹤0.01% 1113
2023
Q1 		– Sell
-679
Closed -$11K – 2184
2022
Q4 		$11K Sell
679
-259
-28% -$4.88K ﹤0.01% 1372
2022
Q3 		$21K Buy
+938
New +$28.4K ﹤0.01% 1392
2022
Q1 		– Sell
-481
Closed -$31K – 2135
2021
Q4 		$31K Buy
+481
New +$38.7K ﹤0.01% 1443
2021
Q2 		– Sell
-2,232
Closed -$836K – 2157
2021
Q1 		$836K Buy
2,232
+939
+73% +$354K 0.06% 308
2020
Q4 		$226K Buy
1,293
+114
+10% +$13.2K 0.02% 784
2020
Q3 		$124K Buy
+1,179
New +$291K 0.02% 684
2018
Q3 		– Sell
-3
Closed -$7K – 2309
2018
Q2 		$7K Buy
+3
New +$8.71K ﹤0.01% 1914
2018
Q1 		– Sell
-2
Closed -$19K – 2718
2017
Q4 		$19K Sell
2
-4
-67% -$41.2K ﹤0.01% 2227
2017
Q3 		$55K Buy
+6
New +$62.1K ﹤0.01% 2213

Other funds holding TRAW

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
VWWMG
Vermillion & White Wealth Management Group Phoenixville, Pennsylvania $174M AUM 15.31% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
DB
Danske Bank Copenhagen K, Denmark $41.5B AUM 29.19% 1-Year Est. Return

Virtu Financial's TRAW Position: Q3 2024 in Review

Virtu Financial sold out of Traws Pharma (TRAW) in Q3 2024, closing a stake of 1,094 shares — an estimated $12K sold.

Virtu Financial first reported a position in TRAW in Q3 2017 and held it in 10 quarters. The position peaked at $836K in Q1 2021. 12 funds tracked by Wall St. Rank hold TRAW as of Q3 2024.

  • Virtu Financial reported no remaining Traws Pharma position as of Q3 2024 after selling out during the quarter.
  • Virtu Financial sold 1,094 Traws Pharma shares in Q3 2024, an estimated $12K.
  • Virtu Financial first reported a position in Traws Pharma in Q3 2017 and held it in 10 quarters.
  • Virtu Financial's Traws Pharma position peaked at $836K in Q1 2021.
  • 12 funds tracked by Wall St. Rank held Traws Pharma as of Q3 2024.

Based on Virtu Financial's 13F filing for Q3 2024, filed 20 Nov 2024.